直近一年間の累計
アクセス数 : ?
ダウンロード数 : ?
ID 118579
タイトル別表記
Clozapine and Antipsychotic Monotherapy
著者
Ochi, Shinichiro Ehime University
Tagata, Hiromi Toho University
Hasegawa, Naomi National Center of Neurology and Psychiatry
Yasui-Furukori, Norio Dokkyo Medical University
Kashiwagi, Hiroko National Center of Neurology and Psychiatry
Kodaka, Fumitoshi The Jikei University School of Medicine
Komatsu, Hiroshi Tohoku University
Tsuboi, Takashi Kyorin University
Tokutani, Akira Hyogo College of Medicine
Ichihashi, Kayo University of Tokyo
Onitsuka, Toshiaki Kyushu University
Muraoka, Hiroyuki Tokyo Women’s Medical University
Iida, Hitoshi Fukuoka University
Ohi, Kazutaka Gifu University
Atake, Kiyokazu Nippon Telegraph and Telephone West Corporation
Kishimoto, Taishiro Keio University
Hori, Hikaru Fukuoka University
Takaesu, Yoshikazu University of the Ryukyus
Takeshima, Masahiro Akita University
Usami, Masahide Kohnodai Hospital
Makinodan, Manabu Nara Medical University
Hashimoto, Naoki Hokkaido University
Fujimoto, Michiko National Center of Neurology and Psychiatry|Osaka University
Furihata, Ryuji Kyoto University
Nagasawa, Tatsuya Kanazawa Medical University
Yamada, Hisashi National Center of Neurology and Psychiatry|Hyogo College of Medicine
Matsumoto, Junya National Center of Neurology and Psychiatry
Miura, Kenichiro National Center of Neurology and Psychiatry
Kido, Mikio Toyama City Hospital|University of Toyama
Hishimoto, Akitoyo Yokohama City University
上野, 修一 Ehime University
Watanabe, Koichiro Kyorin University
Inada, Ken Kitasato University
Hashimoto, Ryota National Center of Neurology and Psychiatry
キーワード
Treatment-resistant schizophrenia
lithium
polypharmacy
guideline
EGUIDE
資料タイプ
学術雑誌論文
抄録
Background: Although clozapine is effective for treatment-resistant schizophrenia (TRS), the rate of clozapine prescription is still low. Whereas antipsychotic monotherapy is recommended in clinical practice guidelines, the rate of antipsychotic polypharmacy is still high. There is little evidence on whether a clozapine prescription influences changes in the rate of monotherapy and polypharmacy, including antipsychotics and other psychotropics. We therefore hypothesized that the rate of antipsychotic monotherapy in patients with TRS who were prescribed clozapine would be higher than that in patients with schizophrenia who were not prescribed clozapine.
Methods: We assessed 8306 patients with schizophrenia nationwide from 178 institutions in Japan from 2016 to 2019. We analyzed the psychotropic prescription data at discharge in patients diagnosed with TRS and with no description of TRS (ND-TRS) based on the diagnosis listed in the discharge summary.
Results: The rate of antipsychotic monotherapy in the TRS with clozapine group (91.3%) was significantly higher than that in the TRS without clozapine group (45.9%; P < 2.0 × 10−16) and the ND-TRS without clozapine group (54.7%; P < 2.0 × 10−16). The rate of antipsychotic monotherapy without any other concomitant psychotropics in the TRS with clozapine group (26.5%) was significantly higher than that in the TRS without clozapine group (12.6%; P = 1.1 × 10−6) and the ND-TRS without clozapine group (17.0%; P = 5.9 × 10−6).
Conclusions: Clozapine prescription could be associated with a high rate of antipsychotic monotherapy. Patients will benefit from the correct diagnosis of TRS and thus from proper clozapine prescription.
掲載誌名
International Journal of Neuropsychopharmacology
ISSN
14611457
14695111
cat書誌ID
AA11545519
出版者
Oxford University Press
25
10
開始ページ
818
終了ページ
826
発行日
2022-06-20
権利情報
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
EDB ID
出版社版DOI
出版社版URL
フルテキストファイル
言語
eng
著者版フラグ
出版社版
部局
医学系